TRCT
IMRN

Tower Research Capital (TRC)’s Immuron IMRN Stock Holding History

Tower Research Capital (TRC)’s Portfolio IMRN Stock Details IMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,037
Closed -$10K – 6278
2022
Q1 		$10K Buy
+3,037
New +$9.79K ﹤0.01% 4311

Other funds holding IMRN

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SC
Stephens Consulting Flint, Michigan $309M AUM 14.46% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Tower Research Capital (TRC)'s IMRN Position: Q2 2022 in Review

Tower Research Capital (TRC) sold out of Immuron (IMRN) in Q2 2022, closing a stake of 3,037 shares — an estimated $10K sold.

Tower Research Capital (TRC) first reported a position in IMRN in Q1 2022 and held it in 1 quarter. The position peaked at $10K in Q1 2022. 4 funds tracked by Wall St. Rank hold IMRN as of Q2 2022.

  • Tower Research Capital (TRC) reported no remaining Immuron position as of Q2 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 3,037 Immuron shares in Q2 2022, an estimated $10K.
  • Tower Research Capital (TRC) first reported a position in Immuron in Q1 2022 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s Immuron position peaked at $10K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Immuron as of Q2 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.